For example, the IL6–JAK–STAT3 pathway, which is involved in the proliferation, survival, invasiveness and metastasis of tumour cells and suppresses the antitumour immune response in TME (Johnson, 2018), had high pathway activity in the low-purity group. Here, IL6 is linked to neoplasm.